Course Description

COMING SOON

In this course you will learn the role that Medication-Assisted Treatment (MAT) plays in the treatment of Opioid Use Disorders and understanding MAT as a part of comprehensive medication-assisted recovery.

The course will include a fundamental understanding of MAT, the types of medication used in treatment, controversy regarding MAT, the myths associated with its use, and how MAT is a critical tool in effective evidence-based treatment of addiction.

Participants will gain understanding of how MAT fits into the overall treatment continuum for persons with Opioid Use Disorder, identify three medications that are proven to be effective in treatment, learn the basic characteristics of the medication, identify which patients may be best suited for each medication, and identify other psychotherapies and activities that enhance a comprehensive addiction treatment program.

DOWNLOAD Course Overview: MAT ASWB ACE 4062.pdf

Counselor Skills Groups

Clinical Intake and Screening, Clinical Assessment, Counseling Services, Case Management, and Discharge and Continuing Care. 

Distance Learning

Hybrid Asynchronous Reading and Video-based Course.

Course Author

Dean Babcock MSW, LCSW, LCAC received his Bachelor of Science degree in Public Affairs and Master of Social Work degree from Indiana University. He is a Licensed Clinical Social Worker and Licensed Clinical Addiction Counselor and has spent his professional career working in health care and mental health care systems in the Indianapolis area.

In 2018 he retired from his role as Associate Vice President at Eskenazi Health, Midtown Community Mental Health Center where he directed both administrative and clinical operations of a comprehensive system of care for persons having mental illness and addictive disorders. His clinical specialty is in the field of addiction treatment, program development, clinical consultation, and driving evidence-based practice implementation in large medical systems.

In addition to his leadership role at Eskenazi, he served as the Site Principal Investigator in the National Institute on Drug Abuse Clinical Trials Network. This collaborative national project develops innovative clinical intervention research to expand the field of addiction treatment.

Dean is a published author on numerous research publications and gives lectures and trainings both locally and nationally related to evidence-based practices in addiction treatment.

He has served on a wide variety of local and national committees, projects and boards, and enjoys helping the public understand the nature of addiction and its treatment. He is the recipient of numerous awards and recognitions for the work he has done in helping the community in which he lives.

Course Reviewer

Subject matter expert, R. Andrew Chambers, M.D., an associate professor of psychiatry, as well as director of the Addiction Psychiatry Fellowship Program and director of the Lab for Translational Neuroscience of Dual Diagnosis & Development at Indiana University Health.

What You Will Learn

  • Discuss:: Medication-Assisted Treatment (MAT) and the role MAT plays in treatment of Opioid Use Disorders (OUD)/Opioid Addiction. The three most common MAT medications: methadone, buprenorphine, and naltrexone.

  • Explain: Why MAT is critical in the fight against OUDs and why it is a model of chronic care management. How each medication works in the brain.

  • Discuss: Myths and controversy associated with MAT.

  • Identify: Three medications used for MAT, the characteristics of each medication, and the type of client each medication may be best for. Other clinical activities to use in conjunction with these medications.

  • Explain: How MAT fits into larger continuum of professional treatment using the National Institute on Drug Abuse (NIDA) principles of effective treatment. Basic laws and regulations surrounding the use of MAT.

Course CE Credits

In partnership with Purdue University College of Pharmacy, Office of Continuing Education, Overdose Lifeline has developed this online, self-paced course for Social Workers.

CE Accreditation Statement:

Medication-Assisted Treatment (MAT): Understanding MAT as Part of Comprehensive Medication-Assisted Recovery, Course #4062, is approved by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program to be offered by Purdue University College of Pharmacy Office of Continuing Education as an individual course. Regulatory boards are the final authority on courses accepted for continuing education credit.

ACE course approval period: 07/06/2023 - 07/06/2025.

Social workers completing this course receive 2.75 general continuing education credits.

Notice to providers of New Jersey SW Continuing Education:

ACE individual course approval meets the NJ Board of Social Work Examiners requirements for individual course approval pursuant to NJ Code 13:44G-6.4.16.

Participation in the ASWB ACE Course Approval Program requires that the provider abide by all the criteria set forth by New Jersey Administrative Code Title 13 Chapter 44 G Subchapter 6.

Notice to providers of New York SW Continuing Education:

New York does not accept ASWB ACE continuing education credits. New York-licensed social workers can complete the course for CE credit using the AMA PRA Category 1 Credit™ (ACCME) is accepted for many clinical continuing education requirements and many societies and credentialing bodies accept the AMA PRA Category 1 Credit™ as an equivalent as long as the topic is relevant to the applicant’s field or discipline. VIEW CE COURSES

Additional Course Notes

  • This course provides 2.75 ASWB ACE continuing education credits - delivered upon 100% course completion, achievement of 80% (minimum) passing grade on the final exam, and completing the course ending survey.

  • The course may be accessed from a computer, tablet or mobile device. Internet access is required as are speakers for audio.

    The following web browsers are supported: Desktop - Firefox, Safari, Chrome, and Edge. Note the course platform does not support Internet Explorer. Mobile - iOS Safari: 11 and up, Chrome, Samsung Internet.

  • The course will remain available in your account for six months - allowing you to complete the course at your own pace and return to the course later for review of key concepts.

  • All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any commercial financial affiliations with ineligible companies related to the content of the presentation or enduring material. All planning committee members, writers, staff and reviewers of Overdose Lifeline and Purdue University have no relationships to disclose.